Product Information
ASPIRIN 325 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0159 per EA under NDC 49483001101. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
325 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483001101
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
4/2/2014
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN 325 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 67.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0159 per EA |
|---|---|
| All-time high | $0.0166 (Jul 10, 2024) |
| All-time low | $0.0091 (May 19, 2021) |
| 52-week high | $0.0160 |
| 52-week low | $0.0153 |
| Median price | $0.0105 |
| Average price | $0.0115 |
| Largest weekly change | -18.8% (Apr 19, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ASPIRIN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN 325 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0159 per EA (NDC 49483001101), effective Jun 24, 2026.
How has the price of ASPIRIN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ASPIRIN 325 MG TABLET has risen 67.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ASPIRIN 325 MG TABLET?
Since Nov 28, 2013, the NADAC for ASPIRIN 325 MG TABLET has ranged from a low of $0.0091 (May 19, 2021) to a high of $0.0166 (Jul 10, 2024), with a median of $0.0105 per EA.
Are there cheaper alternatives to ASPIRIN 325 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ASPIRIN EC 325 MG TABLET, is $0.0149 per EA — about 6% below ASPIRIN 325 MG TABLET.
Who manufactures ASPIRIN 325 MG TABLET?
ASPIRIN 325 MG TABLET (NDC 49483001101) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification